Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Blood|March 23, 2010
Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cellsHaiyan Li, Sungyoul Hong, Jianfei Qian, et al.Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myelomaSiqing Wang, Sungyoul Hong, Michele Wezeman, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2003
Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38Jin Xie, Jianfei Qian, Siqing Wang, et al.Frontiers in Immunology|September 19, 2025
Immunoprevention of triple-negative breast cancer with a novel multivalent vaccineSang Beom Lee, Jianfei Qian, Jing Pan, et al.Cancer Research|October 17, 2008
Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growthSungyoul Hong, Jianfei Qian, Jing Yang, et al.Blood|November 18, 2005
Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myelomaSiqing Wang, Jing Yang, Jianfei Qian, et al.Experimental Hematology|April 27, 2005
Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cellsJin Xie, Jianfei Qian, Jing Yang, et al.Cancer Immunology, Immunotherapy : CII|October 18, 2011
CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myelomaSungyoul Hong, Jianfei Qian, Haiyan Li, et al.Oncotarget|October 9, 2015
CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myelomaLiang Zhang, Enguang Bi, Sungyoul Hong, et al.Pageof 7